Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Emergency Medicine Journal : EMJ
|
March 18, 2017
What is an ROC curve?
Zhe Hui Hoo, Jane Candlish, Dawn Teare
Trials
|
March 2, 2019
Statistical design and analysis in trials of proportionate interventions: a systematic review
Jane Candlish, M Dawn Teare, Judith Cohen, et al.
BMC Medical Research Methodology
|
March 24, 2017
Erratum to: Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study
Jane Candlish, Alexander Pate, Matthew Sperrin, et al.
BMC Medical Research Methodology
|
February 2, 2017
Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study
Jane Candlish, Alexander Pate, Matthew Sperrin, et al.
BMC Medical Research Methodology
|
August 28, 2016
Cohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design
Alexander Pate, Jane Candlish, Matthew Sperrin, et al.
Epidemiology (Cambridge, Mass.)
|
April 15, 2016
Collider Bias Is Only a Partial Explanation for the Obesity Paradox
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Epidemiology (Cambridge, Mass.)
|
December 17, 2016
The Authors Respond
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Epidemiology (Cambridge, Mass.)
|
August 2, 2017
The Authors Respond
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
BMC Medical Research Methodology
|
October 14, 2018
Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study
Jane Candlish, M Dawn Teare, Munyaradzi Dimairo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 5, 2024
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)
Sai-Hong Ou, Hannah Kilvert, Jane Candlish, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Emergency Medicine Journal : EMJ
|
March 18, 2017
What is an ROC curve?
Zhe Hui Hoo, Jane Candlish, Dawn Teare
Trials
|
March 2, 2019
Statistical design and analysis in trials of proportionate interventions: a systematic review
Jane Candlish, M Dawn Teare, Judith Cohen, et al.
BMC Medical Research Methodology
|
March 24, 2017
Erratum to: Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study
Jane Candlish, Alexander Pate, Matthew Sperrin, et al.
BMC Medical Research Methodology
|
February 2, 2017
Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study
Jane Candlish, Alexander Pate, Matthew Sperrin, et al.
BMC Medical Research Methodology
|
August 28, 2016
Cohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design
Alexander Pate, Jane Candlish, Matthew Sperrin, et al.
Epidemiology (Cambridge, Mass.)
|
April 15, 2016
Collider Bias Is Only a Partial Explanation for the Obesity Paradox
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Epidemiology (Cambridge, Mass.)
|
December 17, 2016
The Authors Respond
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Epidemiology (Cambridge, Mass.)
|
August 2, 2017
The Authors Respond
Matthew Sperrin, Jane Candlish, Ellena Badrick, et al.
BMC Medical Research Methodology
|
October 14, 2018
Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study
Jane Candlish, M Dawn Teare, Munyaradzi Dimairo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 5, 2024
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)
Sai-Hong Ou, Hannah Kilvert, Jane Candlish, et al.
Page
of 2